Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2015

Quarterly Financial Data

Schedule of Quarterly Financial Information

	2015 Quarters
	First		Second		Third		Fourth
Net revenues
Finished pharmaceutical products	$	50,872	$	50,075	$	57,902	$	66,092
API		6,014		3,778		5,966		10,820
Total net revenues	$	56,886	$	53,853	$	63,868	$	76,912
Gross profit
Finished pharmaceutical products	$	12,853	$	12,634	$	19,302	$	29,357
API		427		684		(1,724)		3,814
Total gross profit	$	13,280	$	13,318	$	17,578	$	33,171
Net income (loss)	$	(665)	$	(6,647)	$	(3,008)	$	7,533
Weighted-average shares used to compute net income (loss) per share
Basic		44,601		44,849		45,310		45,085
Diluted		44,601		44,849		45,310		46,709
Net income (loss) per share
Basic	$	(0.01)	$	(0.15)	$	(0.07)	$	0.17
Diluted	$	(0.01)	$	(0.15)	$	(0.07)	$	0.16

	2014 Quarters
	First		Second		Third		Fourth
Net revenue
Finished pharmaceutical products	$	45,870	$	48,901	$	53,729	$	49,980
API		—		102		5,982		5,897
Total net revenues	$	45,870	$	49,003	$	59,711	$	55,877
Gross profit
Finished pharmaceutical products	$	12,509	$	14,961	$	12,122	$	13,132
API		—		35		(331)		(1,172)
Total gross profit	$	12,509	$	14,996	$	11,791	$	11,960
Net loss	$	(1,619)	$	(1,180)	$	(5,379)	$	(2,521)
Weighted-average shares used to compute net loss per share
Basic		38,769		39,767		44,644		44,648
Diluted		38,769		39,767		44,644		44,648
Net loss per share
Basic	$	(0.04)	$	(0.03)	$	(0.12)	$	(0.06)
Diluted	$	(0.04)	$	(0.03)	$	(0.12)	$	(0.06)